Schedule 13G ownership disclosure

UNITED THERAPEUTICS CORP DEL COM

Security class unavailable · CUSIP: 91307C102

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,052,047
Percent of class
9.2300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-017847
Form type
SC 13G
Filer
UNITED THERAPEUTICS Corp
CIK
CIK 1082554
Filed
Feb 12, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub